Community Academic Profiles–

Alan M. Garber

Back to Profile

Publication Details

  • The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis.

    Liu H, Michaud K, Nayak S, Karpf DB, Owens DK, Garber AM. Arch Intern Med. 2006; 166 (11): 1209-17

    Teriparatide is a promising new agent for the treatment of osteoporosis.

    PubMedID: 16772249

Stanford Medicine Resources:

Footer Links: